A detailed history of Northern Trust Corp transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 444,847 shares of TNYA stock, worth $1.06 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
444,847
Previous 394,004 12.9%
Holding current value
$1.06 Million
Previous $1.22 Million 29.73%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$1.93 - $3.99 $98,126 - $202,863
50,843 Added 12.9%
444,847 $858,000
Q2 2024

Aug 14, 2024

SELL
$2.72 - $4.99 $9,947 - $18,248
-3,657 Reduced 0.92%
394,004 $1.22 Million
Q1 2024

May 14, 2024

BUY
$2.88 - $6.8 $22,979 - $54,257
7,979 Added 2.05%
397,661 $2.08 Million
Q4 2023

Feb 13, 2024

SELL
$1.73 - $3.39 $68,423 - $134,077
-39,551 Reduced 9.21%
389,682 $1.26 Million
Q3 2023

Nov 13, 2023

BUY
$2.55 - $5.65 $29,643 - $65,681
11,625 Added 2.78%
429,233 $1.09 Million
Q2 2023

Aug 11, 2023

BUY
$2.64 - $7.64 $183,912 - $532,232
69,664 Added 20.02%
417,608 $2.45 Million
Q1 2023

May 15, 2023

BUY
$1.92 - $3.59 $239,677 - $448,146
124,832 Added 55.95%
347,944 $991,000
Q4 2022

Feb 13, 2023

SELL
$1.68 - $3.19 $12,947 - $24,585
-7,707 Reduced 3.34%
223,112 $448,000
Q3 2022

Nov 14, 2022

BUY
$2.9 - $5.88 $25,241 - $51,179
8,704 Added 3.92%
230,819 $670,000
Q2 2022

Aug 12, 2022

SELL
$5.01 - $14.12 $46,813 - $131,937
-9,344 Reduced 4.04%
222,115 $1.25 Million
Q1 2022

May 13, 2022

BUY
$9.41 - $19.3 $861,824 - $1.77 Million
91,586 Added 65.48%
231,459 $2.73 Million
Q4 2021

Feb 08, 2022

BUY
$18.41 - $29.58 $305,293 - $490,525
16,583 Added 13.45%
139,873 $2.65 Million
Q3 2021

Nov 15, 2021

BUY
$15.35 - $26.66 $1.89 Million - $3.29 Million
123,290 New
123,290 $2.55 Million

Others Institutions Holding TNYA

About Tenaya Therapeutics, Inc.


  • Ticker TNYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,364,700
  • Market Cap $98.4M
  • Description
  • Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...
More about TNYA
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.